On May 2nd 2017 SciBase received confirmation that its US patent, protecting the shape of the microneedles that enable detection of malignant melanoma in the skin using electrical impedance, has been approved.

In total SciBase now has 3 patent families approved in the US and an additional family in process.

“Our electrode design is one of the key reasons for the success of our method. It is positive that we further strengthen our patent portfolio in the US, especially as we are in the final stages of our PMA-application.”, says Simon Grant CEO SciBase.